top of page
Hymovis is an injectable solution used to treat knee pain caused byosteoarthritisin patients who did not achieve adequate relief with conservative therapy or over-the-counter pain relievers. Fact Table Formula (C14H21NO11)n License US FDA Bioavailability Poor Legal status OTC Chemical Name hyaluronan Elimination half-life 17 hours to 1.5 days Dosage (Strength) 24 mg/3ml 6 ml 2x3ml Pregnancy No Known Risk Brands Hymovis Protein binding - PubChem CID 24759 MedlinePlus - ChEBI 16336 ATC code D03AX05 DrugBank DB08818 KEGG D08043 Routes of administration Injection

Hymovis (Sodium Hyaluronate Hexadecylamide)

  • Hymovis is available in a set of two 5 mL syringes. Each syringe is for single use only and contains a 3 mL dose of Hymovis that should be injected one week apart. Hymovis should be injected into the intra-articular space of the knee. The contents of the syringe should be used immediately after opening the package. Any remaining Hymovis should be discarded. Ask your doctor or pharmacist any questions you may have.
bottom of page